Stream Health, WPP's "unconference" which took place in Florida earlier this week, provided a diverse and large amount of content in a short amount of time.
Healthcare workers seek out health-related information on their own time, and through internet connections other than ones offered by their employers.
The media company has added managed-markets expertise to its roster, bringing on the former head of IMS Health's global payer/provider division.
Parent company CVS Caremark is changing its name to better reflect "its broader health care commitment."
Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma company to pair with the Crohn's and Colitis Foundation of America.
The refresh launched soon after the company encouraged investors to take a long view of GSK as the firm posted weak respiratory numbers.
Tech site Venturebeat, citing anonymous sources, says doctors are too overwhelmed and weary to evaluate how many steps you took this weekend.
Influential patients are reaching critical mass. What can't they do?
A study indicates consumers stop using them at the six-month mark.
The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.
NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."
He started the Dose of Digital blog in 2008, then left healthcare. Now, after more than two years away, Jonathan Richman says he's back in the business.
The FDA says the OTC remedy maker's online behavior—including Liking customer Facebook posts—has put the company's drugs in unapproved drug territory.
The drugmaker received a notice from the advertising watchdog over promotion of hep. B treatment Viread in a sponsored link on Google AdWords.
Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
The consumer-facing edition of The Merck Manual Go-To Home Guide for Symptoms is being released as a mobile app.
Researchers from Boston Children's Hospital, Harvard Medical School and Brigham and Women's Hospital are offering a bit of internet advice for the Food and Drug Administration: do more.
The networking site's emotion experiment rankles some in the science and political communities.
A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement
Celebrity endorsement, co-pay cards and online edutainment are some of the ways marketers are dueling for attention in the prescription omega-3 space.
GlaxoSmithKline dismissed a marketer over its approach to clinical trial recruiting.
Platform lets pharma firms mine big data, and monitor whether millions spent on ad campaigns or medical education are having the desired effect
Researchers are increasingly using social media to recruit patients, albeit oftentimes in an arms-length manner.
Guidance on promoting products in 140 characters and correcting misinformation serves as a guarded green light, says one observer.
Lawmakers criticized Columbia University chairman and professor of surgery Dr. Mehmet Oz for calling weight-loss supplements miracles on his TV program, despite lacking scientific proof to support those claims.
FDA issued two guidance documents today for industry and its representatives to communicate online about prescription drugs and devices.
The Centers for Medicare and Medicaid Services launched a new site Monday to help patients understand how to use their health coverage.
Recent FDA guidelines for health-tracking apps mean Apple's HealthKit, and similar apps, won't have to jump regulatory hurdles before going live.
The health and lifestyle resource's latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.
The bad-ad watchdog says the promotional website for the weight-loss medication Suprenza leaves out too much information.
Patients are using their time in the waiting room to better prepare for upcoming discussions with their doctor. That makes it a good time for marketers to offer mobile-friendly info, researchers have found.
Shwen Gwee, the social media guru, has joined Digitas Health Lifebrands as VP of social strategy.
The two drugmakers inked a deal under which Sanofi holds rights to market the ED pill to consumers without a prescription, if the drug can make the switch.
The regulator's latest study will use eye-tracking tools.
Texting HCPs may be speedy, but a study finds some built-in risks.
The medical website says the country is in for a bad allergy season.
The two-year collaboration leverages health content from Meredith Vieira's Lives project.
The anniversary celebration for the line-smoothing, migraine-relieving medication is expected to last a year.
The AIDS Healthcare Foundation took out an ad in some WSJ editions saying the drug threatens to "break the bank."
Its "Beauty is Bone Deep" campaign looks at beauty from the inside.
Wego Health announced it has added Todd Kolm as SVP, strategy and insights.
A piece about obesity and Coca-Cola shows the widespread nature of conflict-of-interest discussions and concerns about the sway that honoraria and other goodies may exert on researchers.
Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.
23andMe cofounder Linda Avey is taking crowdsourced patient experiences to the web with a soft July launch of a platform called Curious.
Praised for helping navigate the shift by advertisers into digital, media vet Kim Kadlec is leaving pharma for a new role at AOL.
A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
The manufacturer of the so-called "Botox for eyelashes" found the majority of women it surveyed were worried about thinning fringe.
The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.
Express Scripts notes that these prescriptions may not, in fact, be for ADHD.
The NYT reports that the data on gaming long-term memory is inconclusive.
The Mario Bros. company says health and fun are the way of the future.
The company said it used "inappropriate expressions" in promotions of a blood pressure medication.
The publisher aims to bring patient stories to life through long-form multimedia narratives.
The National Association of Boards of Pharmacy says about 97% of surveyed pharmacy sites fail to comply with laws.
GoQii seeks to convert tracked calories, steps and distance into a philanthropic device.
Movable Ink reports that 65% of Q4 emails were opened on a tablet or smartphone.
TapTrak seeks to apply behavioral tracking to clinical trials.
Pharma has reduced the burden of disease. It can develop a condition-specific app. But getting people to take their medications as prescribed? That's another matter. Larry Dobrow on why biopharma is backing mobile games for their potential to boost adherence and drive behavior change
The latest IMS report shows that 50% of the top 50 pharma companies are not on social media. Executive Director Murray Aitken tells MM&M it is to pharma's detriment.
HHS has bought airtime in markets with high numbers of uninsured patients.
Chronic disease patients seek online support and information, and show little love for branded websites.
Spectrum DNA says its genetic services are at the ready, even if 23andMe's are not.
The drugmaker now owns the @Pfizer handle in addition to @Pfizer_news
The Kaiser Family Foundation's just-launched website, funded by Gilead, addresses healthcare reform from a distinct perspective.
The drugmaker says 20 jobs, or 17% of its workforce, will be gone by the end of the year.
They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.
The voice-activated app costs 99 cents.
Researchers found that most healthcare apps have limited functionality, don't serve patients with multiple needs, and taper off when support is needed most. No wonder adoption is low.
The company says it recaptured some former advertisers and that third-quarter traffic is up compared with last year.
Smartphone users, while in the exam room, are more apt to be in "switch mentality," a study finds.
The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don't work correctly.
An upcoming leadership summit is devoted to exploring whether health social media is driving meaningful change, as well as new ways to engage with health activists.
The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.
The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.
A good percentage of consumers are open to visiting a pharmaceutical company website, an online survey shows, despite a persistent undercurrent of distrust for industry.
The drug maker brought together a group of five established healthcare advocates under the umbrella GLAM, short for Great Life After Menopause. The advocates will keep their distinct voices, which are anything but muted.
For women suffering from breast cancer, online tools appeared to be helpful in battling depression, a randomized trial showed.
Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.
Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
How Shire's new campaign seeks to help diabetics start off on the right foot
The state's first patient portal has officially entered development, and the e-health firm leading the effort said that a former WebMD executive joined its board.
Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.
The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.